• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种α-突触核蛋白病的植物模型:α-突触核蛋白A53T变体在毛状根培养物中的表达导致蛋白质稳态应激和铁代谢失调。

A Plant Model of -Synucleinopathy: Expression of -Synuclein A53T Variant in Hairy Root Cultures Leads to Proteostatic Stress and Dysregulation of Iron Metabolism.

作者信息

Kurepa Jasmina, Bruce Kristen A, Gerhardt Greg A, Smalle Jan A

机构信息

Department of Plant and Soil Sciences, Martin-Gatton College of Agriculture Food and Environment, Kentucky Tobacco Research & Development Center, University of Kentucky, Lexington, KY 40546, USA.

Naprogenix, Inc., UK-AsTeCC, 145 Graham Avenue, Lexington, KY 40506, USA.

出版信息

Appl Biosci (Basel). 2024 Jun;3(2):233-249. doi: 10.3390/applbiosci3020016. Epub 2024 May 20.

DOI:10.3390/applbiosci3020016
PMID:38835931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11149894/
Abstract

Synucleinopathies, typified by Parkinson's disease (PD), entail the accumulation of -synuclein (Syn) aggregates in nerve cells. Various Syn mutants, including the Syn A53T variant linked to early-onset PD, increase the propensity for Syn aggregate formation. In addition to disrupting protein homeostasis and inducing proteostatic stress, the aggregation of Syn in PD is associated with an imbalance in iron metabolism, which increases the generation of reactive oxygen species and causes oxidative stress. This study explored the impact of Syn A53T expression in transgenic hairy roots of four medicinal plants (, , , and ). In all tested plants, Syn A53T expression triggered proteotoxic stress and perturbed iron homeostasis, mirroring the molecular profile observed in human and animal nerve cells. In addition to the common eukaryotic defense mechanisms against proteostatic and oxidative stresses, a plant stress response generally includes the biosynthesis of a diverse set of protective secondary metabolites. Therefore, the hairy root cultures expressing Syn A53T offer a platform for identifying secondary metabolites that can ameliorate the effects of Syn, thereby aiding in the development of possible PD treatments and/or treatments of synucleinopathies.

摘要

以帕金森病(PD)为代表的突触核蛋白病,涉及α-突触核蛋白(Syn)聚集体在神经细胞中的积累。各种Syn突变体,包括与早发性PD相关的Syn A53T变体,增加了Syn聚集体形成的倾向。除了破坏蛋白质稳态并诱导蛋白稳态应激外,PD中Syn的聚集还与铁代谢失衡有关,这会增加活性氧的产生并导致氧化应激。本研究探讨了Syn A53T在四种药用植物(、、和)的转基因毛状根中的表达影响。在所有测试植物中,Syn A53T表达引发了蛋白毒性应激并扰乱了铁稳态,反映了在人类和动物神经细胞中观察到的分子特征。除了针对蛋白稳态和氧化应激的常见真核防御机制外,植物应激反应通常还包括多种保护性次生代谢物的生物合成。因此,表达Syn A53T的毛状根培养物为鉴定可改善Syn作用的次生代谢物提供了一个平台,从而有助于开发可能的PD治疗方法和/或突触核蛋白病的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc4/11149894/3ec8c482e6b9/nihms-1997253-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc4/11149894/acac7dc5b153/nihms-1997253-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc4/11149894/ea650a2904aa/nihms-1997253-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc4/11149894/981acc9679ca/nihms-1997253-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc4/11149894/297b1e54f15d/nihms-1997253-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc4/11149894/b07d8db45be2/nihms-1997253-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc4/11149894/3ec8c482e6b9/nihms-1997253-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc4/11149894/acac7dc5b153/nihms-1997253-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc4/11149894/ea650a2904aa/nihms-1997253-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc4/11149894/981acc9679ca/nihms-1997253-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc4/11149894/297b1e54f15d/nihms-1997253-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc4/11149894/b07d8db45be2/nihms-1997253-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cc4/11149894/3ec8c482e6b9/nihms-1997253-f0006.jpg

相似文献

1
A Plant Model of -Synucleinopathy: Expression of -Synuclein A53T Variant in Hairy Root Cultures Leads to Proteostatic Stress and Dysregulation of Iron Metabolism.一种α-突触核蛋白病的植物模型:α-突触核蛋白A53T变体在毛状根培养物中的表达导致蛋白质稳态应激和铁代谢失调。
Appl Biosci (Basel). 2024 Jun;3(2):233-249. doi: 10.3390/applbiosci3020016. Epub 2024 May 20.
2
Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.人类髓过氧化物酶(hMPO)在帕金森病的黑质神经元中表达,也在 hMPO-α-突触核蛋白-A53T 小鼠模型中表达,与α-突触核蛋白的硝化和聚集增加以及运动障碍恶化相关。
Free Radic Biol Med. 2019 Sep;141:115-140. doi: 10.1016/j.freeradbiomed.2019.05.033. Epub 2019 Jun 6.
3
Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity.α-突触核蛋白抑制线粒体蛋白酶 ClpP 以触发线粒体氧化损伤和神经毒性。
Acta Neuropathol. 2019 Jun;137(6):939-960. doi: 10.1007/s00401-019-01993-2. Epub 2019 Mar 15.
4
genotype regulates pathology and disease progression in synucleinopathy.基因型调节突触核蛋白病中的病理变化和疾病进展。
Sci Transl Med. 2020 Feb 5;12(529). doi: 10.1126/scitranslmed.aay3069.
5
Slow-wave sleep affects synucleinopathy and regulates proteostatic processes in mouse models of Parkinson's disease.慢波睡眠影响帕金森病小鼠模型中的α-突触核蛋白病并调节蛋白质稳态过程。
Sci Transl Med. 2021 Dec 8;13(623):eabe7099. doi: 10.1126/scitranslmed.abe7099.
6
Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models.α-突触核蛋白聚集和溶酶体动态平衡在突触核蛋白病模型中的相互影响。
Transl Neurodegener. 2023 Jun 13;12(1):31. doi: 10.1186/s40035-023-00363-z.
7
A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease.截短的α-突触核蛋白和蛋白酶体在α-突触核蛋白聚集中的促发作用:对帕金森病发病机制的启示
J Biol Chem. 2005 Jun 17;280(24):22670-8. doi: 10.1074/jbc.M501508200. Epub 2005 Apr 19.
8
Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy.α-突触核蛋白羧基端截短和磷酸化延长了类似朊病毒播种的突触核蛋白病小鼠模型中的存活时间。
Neurosci Lett. 2020 Jul 27;732:135017. doi: 10.1016/j.neulet.2020.135017. Epub 2020 May 1.
9
Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model.在基于病毒载体的帕金森病小鼠模型中,蛋白酶 K 抗性 αSyn 物种的去除与细胞存活无关。
Neuropharmacology. 2022 Nov 1;218:109213. doi: 10.1016/j.neuropharm.2022.109213. Epub 2022 Aug 12.
10
Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson's Disease.家族性帕金森病患者诱导多能干细胞衍生神经干细胞的分子缺陷早期迹象。
Biomolecules. 2022 Jun 23;12(7):876. doi: 10.3390/biom12070876.

本文引用的文献

1
Navigating α-Synuclein Aggregation Inhibition: Methods, Mechanisms, and Molecular Targets.探索α-突触核蛋白聚集抑制:方法、机制及分子靶点
Chem Rec. 2024 Feb;24(2):e202300282. doi: 10.1002/tcr.202300282. Epub 2023 Nov 2.
2
Advances in understanding the function of alpha-synuclein: implications for Parkinson's disease.了解 alpha-突触核蛋白功能的进展:对帕金森病的影响。
Brain. 2023 Sep 1;146(9):3587-3597. doi: 10.1093/brain/awad150.
3
Dysregulation of astrocytic Ca signaling and gliotransmitter release in mouse models of α-synucleinopathies.
α-突触核蛋白病小鼠模型中天星细胞 Ca 信号和神经递质释放的失调。
Acta Neuropathol. 2023 May;145(5):597-610. doi: 10.1007/s00401-023-02547-3. Epub 2023 Feb 10.
4
Pharmacological characterization of the small molecule 03A10 as an inhibitor of α-synuclein aggregation for Parkinson's disease treatment.小分子 03A10 作为一种治疗帕金森病的 α-突触核蛋白聚集抑制剂的药理学特性研究。
Acta Pharmacol Sin. 2023 Jun;44(6):1122-1134. doi: 10.1038/s41401-022-01039-6. Epub 2023 Jan 10.
5
A brief history of brain iron accumulation in Parkinson disease and related disorders.帕金森病及相关疾病中脑铁蓄积的简史。
J Neural Transm (Vienna). 2022 Jun;129(5-6):505-520. doi: 10.1007/s00702-022-02505-5. Epub 2022 May 9.
6
Deubiquitylase OTUD3 prevents Parkinson's disease through stabilizing iron regulatory protein 2.去泛素化酶 OTUD3 通过稳定铁调节蛋白 2 预防帕金森病。
Cell Death Dis. 2022 Apr 30;13(4):418. doi: 10.1038/s41419-022-04704-0.
7
Discovery of Neuroprotective Agents Based on a 5-(4-Pyridinyl)-1,2,4-triazole Scaffold.基于 5-(4-吡啶基)-1,2,4-三唑骨架的神经保护剂的发现。
ACS Chem Neurosci. 2022 Mar 2;13(5):581-586. doi: 10.1021/acschemneuro.1c00849. Epub 2022 Feb 18.
8
Beyond Alkaloids: Novel Bioactive Natural Products From Species.超越生物碱:来自物种的新型生物活性天然产物。
Front Pharmacol. 2021 Mar 8;12:638210. doi: 10.3389/fphar.2021.638210. eCollection 2021.
9
New Insights into the Role of Ferritin in Iron Homeostasis and Neurodegenerative Diseases.铁蛋白在铁稳态和神经退行性疾病中的作用新见解
Mol Neurobiol. 2021 Jun;58(6):2812-2823. doi: 10.1007/s12035-020-02277-7. Epub 2021 Jan 28.
10
Reverse engineering Lewy bodies: how far have we come and how far can we go?反向工程路易体:我们已经走了多远,还能走多远?
Nat Rev Neurosci. 2021 Feb;22(2):111-131. doi: 10.1038/s41583-020-00416-6. Epub 2021 Jan 11.